Møller, Henrik
King's College London · Kings Health Partners
4 papers on CoChatORCID 0000-0001-8200-5929
Most cited papers
- Verified
Trends in cervical squamous cell carcinoma incidence in 13 European countries: changing risk and the effects of screening
Bray, F., Loos, A. H., McCarron, P., Weiderpass, E., Arbyn, M., Møller, H., Hakama, M., & Parkin, D. M. (2005) · Cancer Epidemiology, Biomarkers & Prevention
Cervical Cancer and HPV ResearchGlobal Cancer Incidence and Screening
Cited by 370
- Verified
Validation of an RNA cell cycle progression score for predicting death from prostate cancer in a conservatively managed needle biopsy cohort
on behalf of the Transatlantic Prostate Group, Cuzick, J., Stone, S., Fisher, G., Yang, Z. H., North, B. V., Berney, D. M., Beltran, L., Greenberg, D., Møller, H., et al. (2015) · British Journal of Cancer
Prostate Cancer Diagnosis and TreatmentProstate Cancer Treatment and Research
Cited by 155
- Verified
Defining the optimal method for measuring baseline metabolic tumour volume in diffuse large B cell lymphoma
Ilyas, H., Mikhaeel, N. G., Dunn, J. T., Rahman, F., Møller, H., Smith, D., & Barrington, S. F. (2018) · European Journal of Nuclear Medicine and Molecular Imaging
Lymphoma Diagnosis and TreatmentMedical Imaging Techniques and Applications
Cited by 150
- Verified
Suicide in cancer patients in South East England from 1996 to 2005: a population-based study
Robinson, D., Renshaw, C., Okello, C., Møller, H., & Davies, E. A. (2009) · British Journal of Cancer
Suicide and Self-Harm StudiesCancer survivorship and care
Cited by 75
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free